Organigram Global (OGI) Non Operating Investment Income (2018 - 2021)
Organigram Global (OGI) reported Non Operating Investment Income of -$7.3 million for Q2 2021, down 21634.88% year-over-year from N/an in Q2 2020, and down 5476.34% quarter-over-quarter from -$131000.0 in Q1 2021.
Organigram Global (OGI) Non Operating Investment Income (2018 - 2021) Analysis & Trends
Organigram Global (OGI) has 4 years of Non Operating Investment Income data on file, last reported at -$7.3 million in Q2 2021.
- Non Operating Investment Income for Q2 2021 came in at -$7.3 million, down 21634.88% year-over-year; the trailing twelve-month figure through May 2021 was -$2.8 million (down 1967.66% YoY), and the FY2021 annual result was -$12.7 million, changed N/A from the prior year.
- Non Operating Investment Income fell to -$7.3 million in Q2 2021 per OGI's latest filing, from -$131000.0 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $4.7 million in Q4 2020 and troughed at -$7.3 million in Q2 2021.
- A 4-year average of -$269367.0 and a median of -$33609.6 in 2020 frame the typical range for Non Operating Investment Income.
- The sharpest annual moves came in 2020 and 2021: Non Operating Investment Income surged 6388.89% in 2020, then plunged 21634.88% in 2021.
- A 4-year view of Non Operating Investment Income shows it stood at -$246000.0 in 2018, then surged by 129.27% to $72000.0 in 2019, then surged by 6388.89% to $4.7 million in 2020, then sank by 256.36% to -$7.3 million in 2021.
- Business Quant data shows OGI's Non Operating Investment Income at -$7.3 million in Q2 2021, -$131000.0 in Q1 2021, and $4.7 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Organigram Global | 714.36 Mn | 656.41 Mn | 11.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2021 | -7.31 Mn |
| May 31, 2021 | -7.31 Mn |
| Feb 28, 2021 | -131,000.00 |
| Feb 28, 2021 | -131,000.00 |
| Nov 30, 2020 | 4.67 Mn |
| Nov 30, 2020 | 4.67 Mn |
| May 31, 2020 | -33,609.58 |
| May 31, 2020 | -33,609.58 |
| Feb 29, 2020 | -161,000.00 |
| Feb 29, 2020 | -161,000.00 |
| Nov 30, 2019 | 72,000.00 |
| Nov 30, 2019 | 72,000.00 |
| May 31, 2019 | -12,693.45 |
| May 31, 2019 | -12,693.45 |
| Feb 28, 2019 | 721,000.00 |
| Feb 28, 2019 | 721,000.00 |
| Nov 30, 2018 | -246,000.00 |
| Nov 30, 2018 | -246,000.00 |